Improving fracture healing in patients with diabetes
Treatment and Mechanisms of Diabetic Fracture Healing
This study is looking at how diabetes can slow down the healing of broken bones and is testing a new way to help improve healing by using a special gel that releases a growth factor, focusing on a protein called FOXO1 and tiny structures in bone cells that are important for recovery.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11018585 on NIH RePORTER |
What this research studies
This research investigates how diabetes affects the healing of bone fractures and explores new strategies to enhance this process. The study focuses on the role of a specific protein, FOXO1, and the presence of cellular structures called cilia in bone cells, which are crucial for proper healing. By using a specially designed hydrogel that releases a growth factor, the researchers aim to improve the healing outcomes for diabetic patients with fractures. The approach includes both laboratory testing and advanced imaging techniques to assess healing progress.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with diabetes who have experienced bone fractures.
Not a fit: Patients without diabetes or those who have not sustained bone fractures may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for fracture healing in diabetic patients, reducing complications and enhancing recovery.
How similar studies have performed: Other research has shown promising results in enhancing fracture healing through targeted molecular approaches, suggesting potential for success in this novel investigation.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Yang, Shuying — University of Pennsylvania
- Study coordinator: Yang, Shuying
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.